Page 1 of 9
SGS Taiwan Ltd.
台灣檢驗科技股份有限公司
This document is issued by the Company subject to its General Conditions of Service printed overleaf, available on request or accessible at http://www.sgs.com.tw/Terms-and-Conditions
and, for electronic format documents, subject to Terms and Conditions for Electronic Documents at http://www.sgs.com.tw/Terms-and-Conditions.Attention is drawn to the limitation of
liability, indemnification and jurisdiction issues defined therein. Any holder of this document is advised that information contained hereon reflects the Company’s findings at the time of
its intervention only and within the limits of Client’s instructions, if any. The Company’s sole responsibility is to its Client and this document does not exonerate parties to a transaction from
exercising all their rights and obligations under the transaction documents. This document cannot be reproduced except in full, without prior written approval of the Company. Any
unauthorized alteration, forgery or falsification of the content or appearance of this document is unlawful and offenders may be prosecuted to the fullest extent of the law. Unless otherwise
stated the results shown in this test report refer only to the sample(s) tested.
No.38, Wu Chyuan 7th Rd., New Taipei Industrial Park, Wu Ku District, New Taipei City, 24890, Taiwan/ 新北市五股區新北產業園區五權七路38號
t (886-2) 2299-3939 f (886-2) 2298 -1338 www.tw.sgs.com
Member of the SGS Group
測 試 報 告
超微量工業安全實驗室
Ultra Trace Industrial Safety Hygiene
報告編號: PUF21700355 日期: 2021年07月26日 頁數 : 1 of 9
ÌPUF21700355mÎ
全力專注國際股份有限公司
台北市中山區南京東路二段95號11樓
以下測試之樣品係由申請廠商所提供及確認:
產品名稱:
申請廠商:
申請廠商地址:
電話/聯絡人:
樣品包裝:
數量:
樣品保存方式:
產品型號:
產品批號:
製造/國內負責廠商:
製造日期:
有效期限:
收樣日期:
測試日期:
測試結果: -請見下頁- 02-27325025 / 全力專注國際股份有限公司
請參考報告末頁樣品照片
10包
室溫
---
【順暢專科】 Vitabox® LP28超有感複合320億益生菌+SOD蔬果酵素
全力專注國際股份有限公司
台北市中山區南京東路二段95號11樓
20230412
金佳鋒生物科技股份有限公司
2021/04/12
2023/04/12
2021年07月12日
2021年07月12日 ~ 2021年07月26日
Page 2 of 9
SGS Taiwan Ltd.
台灣檢驗科技股份有限公司
This document is issued by the Company subject to its General Conditions of Service printed overleaf, available on request or accessible at http://www.sgs.com.tw/Terms-and-Conditions
and, for electronic format documents, subject to Terms and Conditions for Electronic Documents at http://www.sgs.com.tw/Terms-and-Conditions.Attention is drawn to the limitation of
liability, indemnification and jurisdiction issues defined therein. Any holder of this document is advised that information contained hereon reflects the Company’s findings at the time of
its intervention only and within the limits of Client’s instructions, if any. The Company’s sole responsibility is to its Client and this document does not exonerate parties to a transaction from
exercising all their rights and obligations under the transaction documents. This document cannot be reproduced except in full, without prior written approval of the Company. Any
unauthorized alteration, forgery or falsification of the content or appearance of this document is unlawful and offenders may be prosecuted to the fullest extent of the law. Unless otherwise
stated the results shown in this test report refer only to the sample(s) tested.
No.38, Wu Chyuan 7th Rd., New Taipei Industrial Park, Wu Ku District, New Taipei City, 24890, Taiwan/ 新北市五股區新北產業園區五權七路38號
t (886-2) 2299-3939 f (886-2) 2298 -1338 www.tw.sgs.com
Member of the SGS Group
測 試 報 告
超微量工業安全實驗室
Ultra Trace Industrial Safety Hygiene
報告編號: PUF21700355 日期: 2021年07月26日 頁數 : 2 of 9
ÌPUF21700355mÎ
全力專注國際股份有限公司
台北市中山區南京東路二段95號11樓
測試結果:
測試
結果
---
N.D.
備註:
--- --- ---
2.本測試報告之所有檢驗內容,均依委託事項執行檢驗,如有不實,願意承擔完全責任。
3.本報告不得分離,分離使用無效。
4.若該測試項目屬於定量分析則以「定量極限」表示;若該測試項目屬於定性分析則以「偵測極限」表示。
5.低於定量極限/偵測極限之測定值以「N.D.」或「 陰性」表示。微生物測試低於定量極限以「<定量極限值」表示。
1.測試報告僅就委託者之委託事項提供測試結果,不對產品合法性做判斷。
- END -
本樣品檢測共365項西藥定性分析(項
目詳見附錄)
本測試依實驗室內部方法(TESP-UB-0173,
TESP-UB-0181,TESP-UB-0182),以薄層層
析法(TLC),液相層析離子阱質譜儀
(LC/MS/MS)或氣相層析質譜儀(GC/MS)檢
測。
--- ppm(μg/g)
測試方法 定量/偵測
極限 測試項目 單位
365項西藥定性分析
Page 3 of 9
SGS Taiwan Ltd.
台灣檢驗科技股份有限公司
This document is issued by the Company subject to its General Conditions of Service printed overleaf, available on request or accessible at http://www.sgs.com.tw/Terms-and-Conditions
and, for electronic format documents, subject to Terms and Conditions for Electronic Documents at http://www.sgs.com.tw/Terms-and-Conditions.Attention is drawn to the limitation of
liability, indemnification and jurisdiction issues defined therein. Any holder of this document is advised that information contained hereon reflects the Company’s findings at the time of
its intervention only and within the limits of Client’s instructions, if any. The Company’s sole responsibility is to its Client and this document does not exonerate parties to a transaction from
exercising all their rights and obligations under the transaction documents. This document cannot be reproduced except in full, without prior written approval of the Company. Any
unauthorized alteration, forgery or falsification of the content or appearance of this document is unlawful and offenders may be prosecuted to the fullest extent of the law. Unless otherwise
stated the results shown in this test report refer only to the sample(s) tested.
No.38, Wu Chyuan 7th Rd., New Taipei Industrial Park, Wu Ku District, New Taipei City, 24890, Taiwan/ 新北市五股區新北產業園區五權七路38號
t (886-2) 2299-3939 f (886-2) 2298 -1338 www.tw.sgs.com
Member of the SGS Group
測 試 報 告
超微量工業安全實驗室
Ultra Trace Industrial Safety Hygiene
報告編號: PUF21700355 日期: 2021年07月26日 頁數 : 3 of 9
ÌPUF21700355mÎ
全力專注國際股份有限公司
台北市中山區南京東路二段95號11樓
附 錄
365項西藥定性分析測試項目及偵測極限(LOD)彙整表: 單位:
CAS NO. LOD LOD
51-28-5 3600 3300
22348-31-8 900 900
566-19-8 3000 1800
103-90-2 300 300
147676-78-6 1500 348
831217-01-7 600 900
968-81-0 750 4500
62-44-2 3600 3225
1261351-28-3 600 1050
1837-57-6 2832 108
315-30-0 600 600
18683-91-5 600 600
317-34-0 4500 60
58-15-1 900 1200
385769-84-6 900 60
549-18-8 750 1800
88150-42-9 300 1950
26787-78-0 4320 600
300-62-9 375 1650
69-53-4 2700 3600
58-00-4 600 3000
50-78-2 600 600
68844-77-9 150 3000
29122-68-7 300 3600
134523-00-5 420 150
51-55-8 150 600
330784-47-9 600 1650
1134-47-0 300 1500
57-44-3 750 375
86541-75-5 450 2400
2156-27-6 600 150
Barbital Carisoprodol 78-44-4
Benazepril Carvedilol 72956-09-3
Benproperine Cefamandole nafate 42540-40-9
Amoxicillin Bucetin 1083-57-4
Aspirin Caffeine 58-08-2
Amphetamine Bufexamac 2438-72-4
Ampicillin Buspirone 36505-84-7
Acetildenafil Betamethasone 378-44-9
Avanafil Carbinoxamine 486-16-8
Baclofen Carbodenafil 944241-52-5
Atorvastatin Carbetapentane 77-23-6
Atropine Carbimazole 22232-54-8
Astemizole Camylofine 54-30-8
Atenolol Carbamazepine 298-46-4
Apomorphine Butropium 107080-63-7
603-50-9
Acetylvardenafil Betamethasone Dipropionate 5593-20-4
Acrinol Betamethasone Valerate 2152-44-5
Acetohexamide Betamethasone 21 Acetate 987-24-6
Acetophenetidin Betamethasone Benzoate 22298-29-9
ppm(μg/g)
測試項目 測試項目 CAS NO.
Amlodipine Bromvalerylurea 496-67-3
Aminotadalafil Bromopride 4093-35-0
Amitriptyline Brompheniramine 86-22-6
Aminophylline Bisoprolol Fumarate 104344-23-2
Aminopyrine Bromhexine 3572-43-8
Allopurinol Bezafibrate 41859-67-0
Ambroxol Bisacodyl
Acetil acid Benzydamine 642-72-8
7-keto-Dehydroepiandrosterone Benzhexol 144-11-6
Acetaminophen Benzocaine 94-09-7
2,4-Dinitrophenol Benzathine-penicillin 41372-02-5
2-Diphenylmethylpyrrolidine Benzbromarone 3562-84-3
Page 4 of 9
SGS Taiwan Ltd.
台灣檢驗科技股份有限公司
This document is issued by the Company subject to its General Conditions of Service printed overleaf, available on request or accessible at http://www.sgs.com.tw/Terms-and-Conditions
and, for electronic format documents, subject to Terms and Conditions for Electronic Documents at http://www.sgs.com.tw/Terms-and-Conditions.Attention is drawn to the limitation of
liability, indemnification and jurisdiction issues defined therein. Any holder of this document is advised that information contained hereon reflects the Company’s findings at the time of
its intervention only and within the limits of Client’s instructions, if any. The Company’s sole responsibility is to its Client and this document does not exonerate parties to a transaction from
exercising all their rights and obligations under the transaction documents. This document cannot be reproduced except in full, without prior written approval of the Company. Any
unauthorized alteration, forgery or falsification of the content or appearance of this document is unlawful and offenders may be prosecuted to the fullest extent of the law. Unless otherwise
stated the results shown in this test report refer only to the sample(s) tested.
No.38, Wu Chyuan 7th Rd., New Taipei Industrial Park, Wu Ku District, New Taipei City, 24890, Taiwan/ 新北市五股區新北產業園區五權七路38號
t (886-2) 2299-3939 f (886-2) 2298 -1338 www.tw.sgs.com
Member of the SGS Group
測 試 報 告
超微量工業安全實驗室
Ultra Trace Industrial Safety Hygiene
報告編號: PUF21700355 日期: 2021年07月26日 頁數 : 4 of 9
ÌPUF21700355mÎ
全力專注國際股份有限公司
台北市中山區南京東路二段95號11樓
附 錄
365項西藥定性分析測試項目及偵測極限(LOD)彙整表: 單位:
CAS NO. LOD LOD
25953-19-9 1050 1500
113826-44-1 300 3000
63527-52-6 150 4770
73384-59-5 4224 600
169590-42-5 900 750
15686-71-2 75 750
38821-53-3 81 750
282526-98-1 1500 3600
83881-51-0 159 1500
56-75-7 1200 600
58-25-3 300 60
55-56-1 2400 1200
80-77-3 60 900
171489-59-1 1500 1500
58-94-6 750 300
113-92-8 1200 450
50-53-3 300 600
94-20-2 600 375
57-62-5 600 450
95-25-0 1050 600
51481-61-9 1500 3000
298-57-7 600 450
85721-33-1 240 150
21898-19-1 900 300
21462-39-5 456 150
24729-96-2 150 3000
13364-32-4 375 150
25122-46-7 2400 375
637-07-0 1500 150
1622-61-3 150 900
4205-90-7 300 450
Ciprofloxacin(CFA) Dihydroergotamine 511-12-6
Clenbuterol Diltiazem 42399-41-7
Cimetidine Difloxacin 98106-17-3
Cinnarizine Digitoxin 71-63-6
Clobenzorex Dimetridazole 551-92-8
Clobetasol Propionate Diphenhydramine 58-73-1
Clindamycin HCl Dimenhydrinate 523-87-5
Clindamycin phosphate Dimethylsildenafil 496835-35-9
Clonidine Dipyridamole 58-32-2
Clofibrate Diphenylhydantoin 57-41-0
Clonazepam Diprophylline 479-18-5
Chlorhexidine Dexamethasone 50-02-2
Cetirizine Cyproheptadine 129-03-3
Chloramphenicol Desacetyl bisacodyl 603-41-8
Chlorzoxazone Diethylstilbestrol 56-53-1
Chlorpromazine Diclofenac 15307-86-5
Chlorpropamide Dicyclomine 77-19-0
Chlortetracycline Diethylpropion 39648-50-5
Chlorothiazide Diazepam 439-14-5
Chlorpheniramine Dibucaine 85-79-0
Chlormezanone Dexamethasone phosphate 312-93-6
Chloropretadalafil Dextromethorphan 125-71-3
Chlordiazepoxide Desacetyl diltiazem 42399-40-6
Cefoperazone dihydrate Clotrimazole 23593-75-1
ppm(μg/g)
測試項目 測試項目 CAS NO.
Cephradine Cortisone 53-06-5
Cetilistat Cortisone acetate 50-04-4
Celecoxib Cocaine 50-36-2
Cephalexin Colchicine 64-86-8
Cefotaxime Cloxacillin Sodium 7081-44-9
Ceftriaxone Clozapine 5786-21-0
Cefazolin Cloperastine 3703-76-2
Page 5 of 9
SGS Taiwan Ltd.
台灣檢驗科技股份有限公司
This document is issued by the Company subject to its General Conditions of Service printed overleaf, available on request or accessible at http://www.sgs.com.tw/Terms-and-Conditions
and, for electronic format documents, subject to Terms and Conditions for Electronic Documents at http://www.sgs.com.tw/Terms-and-Conditions.Attention is drawn to the limitation of
liability, indemnification and jurisdiction issues defined therein. Any holder of this document is advised that information contained hereon reflects the Company’s findings at the time of
its intervention only and within the limits of Client’s instructions, if any. The Company’s sole responsibility is to its Client and this document does not exonerate parties to a transaction from
exercising all their rights and obligations under the transaction documents. This document cannot be reproduced except in full, without prior written approval of the Company. Any
unauthorized alteration, forgery or falsification of the content or appearance of this document is unlawful and offenders may be prosecuted to the fullest extent of the law. Unless otherwise
stated the results shown in this test report refer only to the sample(s) tested.
No.38, Wu Chyuan 7th Rd., New Taipei Industrial Park, Wu Ku District, New Taipei City, 24890, Taiwan/ 新北市五股區新北產業園區五權七路38號
t (886-2) 2299-3939 f (886-2) 2298 -1338 www.tw.sgs.com
Member of the SGS Group
測 試 報 告
超微量工業安全實驗室
Ultra Trace Industrial Safety Hygiene
報告編號: PUF21700355 日期: 2021年07月26日 頁數 : 5 of 9
ÌPUF21700355mÎ
全力專注國際股份有限公司
台北市中山區南京東路二段95號11樓
附 錄
365項西藥定性分析測試項目及偵測極限(LOD)彙整表: 單位:
CAS NO. LOD LOD
68-89-3 600 3600
1333233-46-7 1500 1200
74191-85-8 2400 600
564-25-0 576 150
469-21-6 60 1200
536-43-6 3600 600
27220-47-9 150 4500
93106-60-6 3090 3000
10402-90-1 300 4800
114-07-8 240 2400
29975-16-4 60 3000
50-28-2 1200 900
50-50-0 600 450
50-27-1 60 2400
53-16-7 30 1620
57-63-6 30 150
434-03-7 600 1350
938-73-8 600 450
965-90-2 30 600
41340-25-4 600 750
31637-97-5 3000 600
76824-35-6 750 1200
36330-85-5 1875 1650
458-24-2 375 1500
49562-28-9 150 900
13392-18-2 750 1200
98319-26-7 3000 1200
15301-69-6 900 60
167933-07-5 3600 2400
86386-73-4 480 1200
530-78-9 4050 302.4
Finasteride (Proscar) Imidazosagatriazinone 139756-21-1
Flavoxate Imipramine 50-49-7
Fenofibrate Hydroxyzine 2192-20-3
Fenoterol Ibuprofen 15687-27-1
Flufenamic acid Isoniazid 54-85-3
Flibanserin Indapamide 26807-65-8
Fluconazole Indomethacin 53-86-1
Estrone Haloperidol 52-86-8
Ethinyl estradiol Homatropine 87-00-3
Estradiol benzoate Griseofulvin 126-07-8
Estriol Guaifenesin 93-14-1
Ethylestrenol Hydrochlorothiazide 58-93-5
Etodolac Hydrocortisone 50-23-7
Ethisterone Homosildenafil 642928-07-2
Ethoxybenzamide Hydralazine 86-54-4
Fenbufen Hydroxythiohomosildenafil 479073-82-0
Fenfluramine Hydroxyvardenafil 224785-98-2
Etofibrate Hydroxyacetildenafil 147676-56-0
Famotidine Hydroxyhomosildenafil 139755-85-4
Doxazosin Fluoxymesterone 76-43-7
Doxycycline Flurbiprofen 5104-49-4
Dipyrone Fluocinonide 356-12-7
Dithio-desmethyl-carbodenafil Fluoxetine 54910-89-3
Econazole Gemfibrozil 25812-30-0
Enrofloxacin Gendenafil 147676-66-2
Doxylamine Fluvastatin 93957-54-1
Dyclonine Hydrochloride Furosemide 54-31-9
Estazolam Glipizide 29094-61-9
Estradiol Glycopyrronium 740028-90-4
Eprazinone Glibenclamide 10238-21-8
Erythromycin Glimepiride 93479-97-1
ppm(μg/g)
測試項目 測試項目 CAS NO.
Page 6 of 9
SGS Taiwan Ltd.
台灣檢驗科技股份有限公司
This document is issued by the Company subject to its General Conditions of Service printed overleaf, available on request or accessible at http://www.sgs.com.tw/Terms-and-Conditions
and, for electronic format documents, subject to Terms and Conditions for Electronic Documents at http://www.sgs.com.tw/Terms-and-Conditions.Attention is drawn to the limitation of
liability, indemnification and jurisdiction issues defined therein. Any holder of this document is advised that information contained hereon reflects the Company’s findings at the time of
its intervention only and within the limits of Client’s instructions, if any. The Company’s sole responsibility is to its Client and this document does not exonerate parties to a transaction from
exercising all their rights and obligations under the transaction documents. This document cannot be reproduced except in full, without prior written approval of the Company. Any
unauthorized alteration, forgery or falsification of the content or appearance of this document is unlawful and offenders may be prosecuted to the fullest extent of the law. Unless otherwise
stated the results shown in this test report refer only to the sample(s) tested.
No.38, Wu Chyuan 7th Rd., New Taipei Industrial Park, Wu Ku District, New Taipei City, 24890, Taiwan/ 新北市五股區新北產業園區五權七路38號
t (886-2) 2299-3939 f (886-2) 2298 -1338 www.tw.sgs.com
Member of the SGS Group
測 試 報 告
超微量工業安全實驗室
Ultra Trace Industrial Safety Hygiene
報告編號: PUF21700355 日期: 2021年07月26日 頁數 : 6 of 9
ÌPUF21700355mÎ
全力專注國際股份有限公司
台北市中山區南京東路二段95號11樓
附 錄
365項西藥定性分析測試項目及偵測極限(LOD)彙整表: 單位:
CAS NO. LOD LOD
65277-42-1 300 900
22071-15-4 450 1500
34580-14-8 60 60
137-58-6 60 750
154-21-2 1710 600
6893-02-3 3600 150
98079-51-7 1500 300
846-49-1 300 384
616202-92-7 900 2370
10262-69-8 150 750
22232-71-9 1950 300
569-65-3 60 900
61-68-7 900 3000
73-31-4 1200 3000
71125-38-7 4500 3000
57-42-1 150 3000
59-47-2 150 3000
100-92-5 240 300
57-53-4 375 2550
657-24-9 300 60
537-46-2 750 600
521-10-8 2400 540
72-63-9 600 600
72-44-6 900 450
50-11-3 750 4410
60-56-0 300 300
41372-08-1 1620 2400
83-43-2 750 600
58-18-4 600 300
364-62-5 750 150
Metoprolol 51384-51-1 150 Norgestrel 6533-00-2 600
Methyltestosterone Norfloxacin 70458-96-7
Metoclopramide Norfludiazepam 2886-65-9
Meprobamate Nicametate 3099-52-3
Metformin Nicotine 54-11-5
Mephenesin N-Didesmethylsibutramine 84467-54-9
Mephentermine Nefopam 13669-70-0
Methandrostenolone Nitrazepam 146-22-5
Methaqualone Nitrofurantoin 67-20-9
Methamphetamine Nifedipine 21829-25-4
Methandriol Nifuroxazide 965-52-6
Methyl DOPA-Sesquihydrate Noraminopyrine 519-98-2
Methylprednisolone Norethisterone 68-22-4
Metharbital Nitrofurazone 59-87-0
Methimazole Noracetildenafil 949091-38-7
Lomefloxacin Nalidixic acid 389-08-2
Lorazepam Naloxone 465-65-6
Lincomycin Minoxidil 38304-91-5
Liothyronine Morphine 57-27-2
Mazindol Naphazoline Hydrochloride 835-31-4
Meclizine Naproxen 22204-53-1
Lorcaserin Naltrexone 16590-41-3
Maprotiline Nandrolone 434-22-0
Meloxicam N-Desmethylsibutramine 168835-59-4
Meperidine N-Desmethylsildenafil 139755-82-1
Mefenamic acid N-Desethylvardenafil 448184-46-1
Melatonin N-Desmethylacetildenafil 147676-55-9
ppm(μg/g)
測試項目 測試項目 CAS NO.
Ketotifen fumarate Midazolam 59467-70-8
Lidocaine Minocycline 10118-90-8
Ketoconazole Metronidazole 443-48-1
Ketoprofen Mexiletine 31828-71-4
Page 7 of 9
SGS Taiwan Ltd.
台灣檢驗科技股份有限公司
This document is issued by the Company subject to its General Conditions of Service printed overleaf, available on request or accessible at http://www.sgs.com.tw/Terms-and-Conditions
and, for electronic format documents, subject to Terms and Conditions for Electronic Documents at http://www.sgs.com.tw/Terms-and-Conditions.Attention is drawn to the limitation of
liability, indemnification and jurisdiction issues defined therein. Any holder of this document is advised that information contained hereon reflects the Company’s findings at the time of
its intervention only and within the limits of Client’s instructions, if any. The Company’s sole responsibility is to its Client and this document does not exonerate parties to a transaction from
exercising all their rights and obligations under the transaction documents. This document cannot be reproduced except in full, without prior written approval of the Company. Any
unauthorized alteration, forgery or falsification of the content or appearance of this document is unlawful and offenders may be prosecuted to the fullest extent of the law. Unless otherwise
stated the results shown in this test report refer only to the sample(s) tested.
No.38, Wu Chyuan 7th Rd., New Taipei Industrial Park, Wu Ku District, New Taipei City, 24890, Taiwan/ 新北市五股區新北產業園區五權七路38號
t (886-2) 2299-3939 f (886-2) 2298 -1338 www.tw.sgs.com
Member of the SGS Group
測 試 報 告
超微量工業安全實驗室
Ultra Trace Industrial Safety Hygiene
報告編號: PUF21700355 日期: 2021年07月26日 頁數 : 7 of 9
ÌPUF21700355mÎ
全力專注國際股份有限公司
台北市中山區南京東路二段95號11樓
附 錄
365項西藥定性分析測試項目及偵測極限(LOD)彙整表: 單位:
CAS NO. LOD LOD
371959-09-0 1000 1500
171596-36-4 1500 1350
128-62-1 300 600
849-55-8 4500 300
82419-36-1 1920 1200
73590-58-6 1200 750
96829-58-2 375 750
83-98-7 300 30
468-61-1 120 900
126-27-2 150 300
5633-20-5 4635 600
434-07-1 1050 300
129-20-4 450 2400
125-53-1 75 3000
79-57-2 960 1350
58-74-2 1560 3000
359-83-1 30 2400
76-74-4 150 300
6493-05-6 2400 600
62-44-2 3600 1200
94-78-0 750 120
114-86-3 900 3000
50-06-6 900 3000
77-09-8 600 37.5
122-09-8 1500 600
50-60-2 1500 900
50-33-9 750 450
59-42-7 2850 150
14838-15-4 60 900
111025-46-8 1200 1200
147676-50-4 3000 1200
Phenobarbital Rosiglitazone 122320-73-4
Phenolphthalein Salbutamol 18559-94-9
Phenazopyridine Rifampin 13292-46-1
Phenformin Rimonabant 168273-06-1
Phenylbutazone Santonin 481-06-1
Phenylephrine Scopolamine 6533-68-2
Phentermine Salicylamide 65-45-2
Phentolamine Salicylic acid 69-72-7
Piperiacetildenafil Sildenafil 139755-83-2
Phenylpropanolamine Secobarbital 76-73-3
Pioglitazone Sibutramine 106650-56-0
Oxybutynin Progesterone 57-83-0
Oxymetholone Promethazine 60-87-7
Oxeladin Probenecid 57-66-9
Oxethazaine Procaine 59-46-1
Oxytetracycline (OTC) Propranolol 525-66-6
Papaverine Propyphenazone 479-92-5
Oxyphenbutazone Propafenone 54063-53-5
Oxyphencyclimine Propantheline 298-50-0
Pentoxifylline Ranitidine 66357-59-3
Phenacetin Reserpine 50-55-5
Pentazocine Quetiapine 111974-69-7
Pentobarbital Quinine 130-95-0
ppm(μg/g)
測試項目 測試項目 CAS NO.
Noscapine Piroxicam 36322-90-4
Nylidrin Prazosin 19216-56-9
Norneosildenafil Piperidenafil 224788-34-5
Nortadalafil Pirenzepine 28797-61-7
Orlistat Prilocaine 721-50-6
Orphenadrine Primidone 125-33-7
Ofloxacin Prednisolone 50-24-8
Omeprazole Prednisone 53-03-2
Page 8 of 9
SGS Taiwan Ltd.
台灣檢驗科技股份有限公司
This document is issued by the Company subject to its General Conditions of Service printed overleaf, available on request or accessible at http://www.sgs.com.tw/Terms-and-Conditions
and, for electronic format documents, subject to Terms and Conditions for Electronic Documents at http://www.sgs.com.tw/Terms-and-Conditions.Attention is drawn to the limitation of
liability, indemnification and jurisdiction issues defined therein. Any holder of this document is advised that information contained hereon reflects the Company’s findings at the time of
its intervention only and within the limits of Client’s instructions, if any. The Company’s sole responsibility is to its Client and this document does not exonerate parties to a transaction from
exercising all their rights and obligations under the transaction documents. This document cannot be reproduced except in full, without prior written approval of the Company. Any
unauthorized alteration, forgery or falsification of the content or appearance of this document is unlawful and offenders may be prosecuted to the fullest extent of the law. Unless otherwise
stated the results shown in this test report refer only to the sample(s) tested.
No.38, Wu Chyuan 7th Rd., New Taipei Industrial Park, Wu Ku District, New Taipei City, 24890, Taiwan/ 新北市五股區新北產業園區五權七路38號
t (886-2) 2299-3939 f (886-2) 2298 -1338 www.tw.sgs.com
Member of the SGS Group
測 試 報 告
超微量工業安全實驗室
Ultra Trace Industrial Safety Hygiene
報告編號: PUF21700355 日期: 2021年07月26日 頁數 : 8 of 9
ÌPUF21700355mÎ
全力專注國際股份有限公司
台北市中山區南京東路二段95號11樓
附 錄
365項西藥定性分析測試項目及偵測極限(LOD)彙整表: 單位:
CAS NO. LOD LOD
79902-63-9 600 750
52-01-7 300 2400
10418-03-8 2100 600
57-24-9 900 600
68-35-9 600 450
122-11-2 750 450
127-79-7 450 300
57-68-1 600 450
144-82-1 600 300
723-46-6 600 150
80-35-3 450 900
1220-83-3 4650 375
63-74-1 375 450
144-83-2 2400 3000
59-40-5 4740 900
72-14-0 600 4800
57-96-5 750 150
515-64-0 3000 1500
127-69-5 450 60
38194-50-2 750 3600
15676-16-1 1140 1800
94-07-5 450 1800
171596-29-5 600 60
91161-71-6 300 1050
50679-08-8 450 1500
58-22-0 600 60
57-85-2 3000 300
94-24-6 600 --
Testosterone propionate Zolpidem 82626-48-0
Tetracaine -- --
Terfenadine Yohimbine 146-48-5
Testosterone Zolazepam HCl 31352-82-6
Sulfaquinoxaline Triamcinolone 124-94-7
Sulfathiazole Triamcinolone acetonide 76-25-5
Sulfanilamide Topiramate 97240-79-4
Sulfapyridine Trazodone hydrochloride 19794-93-5
Sulfisoxazole Triprolidine 486-12-4
Sulindac Usnic acid 125-46-2
Sulfinpyrazone Triazolam 28911-01-5
Sulfisomidine Trimethoprim 738-70-5
Tadalafil Verapamil 152-11-4
Terbinafine Xanthinol Niacinate 437-74-1
Sulpiride Vardenafil 224785-90-4
Synephrine Vardenafil analogue(Molecular weight312.37) 224789-21-3
Stanozolol Theobromine 83-67-0
Strychnine Theophylline 58-55-9
Simvastatin Tetracycline 60-54-8
Spironolactone Tetramethylpyrazine 1124-11-4
Sulfamerazine Thioridazine 50-52-2
Sulfamethazine Thiosildenafil 479073-79-5
Sulfadiazine Thiodimethylsildenafil 856190-47-1
Sulfadimethoxine Thiohomosildenafil 479073-80-8
Sulfamethoxypyridazine Tinidazole 19387-91-8
Sulfamonomethoxine Tolbutamide 64-77-7
Sulfamethizole Tiletamine 14176-49-9
Sulfamethoxazole Timolol Maleate 26921-17-5
ppm(μg/g)
測試項目 測試項目 CAS NO.
Page 9 of 9
SGS Taiwan Ltd.
台灣檢驗科技股份有限公司
This document is issued by the Company subject to its General Conditions of Service printed overleaf, available on request or accessible at http://www.sgs.com.tw/Terms-and-Conditions
and, for electronic format documents, subject to Terms and Conditions for Electronic Documents at http://www.sgs.com.tw/Terms-and-Conditions.Attention is drawn to the limitation of
liability, indemnification and jurisdiction issues defined therein. Any holder of this document is advised that information contained hereon reflects the Company’s findings at the time of
its intervention only and within the limits of Client’s instructions, if any. The Company’s sole responsibility is to its Client and this document does not exonerate parties to a transaction from
exercising all their rights and obligations under the transaction documents. This document cannot be reproduced except in full, without prior written approval of the Company. Any
unauthorized alteration, forgery or falsification of the content or appearance of this document is unlawful and offenders may be prosecuted to the fullest extent of the law. Unless otherwise
stated the results shown in this test report refer only to the sample(s) tested.
No.38, Wu Chyuan 7th Rd., New Taipei Industrial Park, Wu Ku District, New Taipei City, 24890, Taiwan/ 新北市五股區新北產業園區五權七路38號
t (886-2) 2299-3939 f (886-2) 2298 -1338 www.tw.sgs.com
Member of the SGS Group
測 試 報 告
超微量工業安全實驗室
Ultra Trace Industrial Safety Hygiene
報告編號: PUF21700355 日期: 2021年07月26日 頁數 : 9 of 9
ÌPUF21700355mÎ
全力專注國際股份有限公司
台北市中山區南京東路二段95號11樓
樣品照片